Quest for Growth Positive developments in unquoted portfolio
6 April 2021
During the first quarter of 2021, the Quest for Growth portfolio continued to evolve positively. In the unquoted companies and venture capital funds segments, several events positively impacted Quest for Growth's net asset value.
In February, Diagenode was acquired by the American Hologic for 130 million euros. Together with other positive trends in Capricorn Health-tech Fund, this had a positive impact on the results of Quest for Growth amounting to more than 1 million euros. This result has already been included in Quest for Growth's net asset value at the end of February 2021, which was published on 4 March 2021.
Other positive developments led to further valuation adjustments in the unquoted companies and venture capital funds segments in March. Among other things, an amount of approximately 3 million euros or 0.18 euro per share was added to the net asset value of 31 March 2021 under the heading ‘Value adjustments unquoted companies and venture capital funds’. This net asset value will be published on Thursday, 8 April 2021. Further explanation of these trends will be provided as soon as more information is available and may be made public.